MA
PPH icon

Montag & Associates’s VanEck Pharmaceutical ETF PPH Stock Holding History

Montag & Associates’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-660
Closed -$58.1K – 1146
2025
Q2 		$58.1K Hold
660
– – ﹤0.01% 560
2025
Q1 		$60.1K Hold
660
– – ﹤0.01% 576
2024
Q4 		$56.9K Hold
660
– – ﹤0.01% 586
2024
Q3 		$62.7K Hold
660
– – ﹤0.01% 566
2024
Q2 		$60.4K Hold
660
– – ﹤0.01% 558
2024
Q1 		$59.9K Hold
660
– – ﹤0.01% 555
2023
Q4 		$53.7K Hold
660
– – ﹤0.01% 569
2023
Q3 		$52.7K Sell
660
-720
-52% -$58.1K ﹤0.01% 545
2023
Q2 		$109K Hold
1,380
– – 0.01% 466
2023
Q1 		$107K Hold
1,380
– – 0.01% 458
2022
Q4 		$107K Hold
1,380
– – 0.01% 440
2022
Q3 		$93K Hold
1,380
– – 0.01% 445
2022
Q2 		$106K Hold
1,380
– – 0.01% 430
2022
Q1 		$110K Hold
1,380
– – 0.01% 454
2021
Q4 		$106K Hold
1,380
– – 0.01% 468
2021
Q3 		$100K Hold
1,380
– – 0.01% 472
2021
Q2 		$101K Hold
1,380
– – 0.01% 469
2021
Q1 		$95K Hold
1,380
– – 0.01% 476
2020
Q4 		$92K Buy
+1,380
New +$88.4K 0.01% 462
2016
Q3 		– Sell
-3,480
Closed -$204K – 250
2016
Q2 		$204K Hold
3,480
– – 0.03% 232
2016
Q1 		$200K Sell
3,480
-5,290
-60% -$313K 0.03% 226
2015
Q4 		$573K Hold
8,770
– – 0.08% 157
2015
Q3 		$552K Hold
8,770
– – 0.09% 157
2015
Q2 		$620K Hold
8,770
– – 0.09% 167
2015
Q1 		$616K Sell
8,770
-11,650
-57% -$790K 0.09% 172
2014
Q4 		$1.31M Buy
20,420
+1,200
+6% +$76.4K 0.2% 124
2014
Q3 		$1.22M Sell
19,220
-5,890
-23% -$365K 0.2% 124
2014
Q2 		$1.56M Sell
25,110
-25,260
-50% -$1.5M 0.25% 111
2014
Q1 		$2.94M Buy
50,370
+1,000
+2% +$56.5K 0.5% 71
2013
Q4 		$2.62M Sell
49,370
-170
-0.3% -$8.61K 0.45% 75
2013
Q3 		$2.37M Hold
49,540
– – 0.44% 75
2013
Q2 		$2.25M Buy
+49,540
New +$2.29M 0.46% 72

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Montag & Associates's PPH Position: Q3 2025 in Review

Montag & Associates sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2025, closing a stake of 660 shares — an estimated $58.1K sold.

Montag & Associates first reported a position in PPH in Q2 2013 and held it in 32 quarters. The position peaked at $2.94M in Q1 2014. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2025.

  • Montag & Associates reported no remaining VanEck Pharmaceutical ETF position as of Q3 2025 after selling out during the quarter.
  • Montag & Associates sold 660 VanEck Pharmaceutical ETF shares in Q3 2025, an estimated $58.1K.
  • Montag & Associates first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 32 quarters.
  • Montag & Associates's VanEck Pharmaceutical ETF position peaked at $2.94M in Q1 2014.
  • 127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2025.

Based on Montag & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.